Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
Charalampos Charalampous(Mayo Clinic), Taxiarchis Kourelis(Mayo Clinic in Arizona)
Cited by 31
Related Papers
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
|Blood|2017|340
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
|Blood Cancer Journal|2018|288
Energy Management and Control of a Flywheel Storage System for Peak Shaving Applications
|IEEE Transactions on Smart Grid|2021|80
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis
|Cancer Research Communications|2022|40